RPIDRapid Micro Biosystems Inc. Class A Common Stock
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care product…
Industry Peers
Medical Devices| Headline | Source | Time |
|---|---|---|
Older | ||
 Down 25.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Rapid Micro Biosystems (RPID) The heavy selling pressure might have exhausted for Rapid Micro Biosystems (RPID) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal. | ||
 Rapid Micro Biosystems (RPID) Q2 2026 Earnings Call Transcript Record gross margins and 200th system milestone signal momentum toward profitability. | ||
 Rapid Micro Biosystems (RPID) Upgraded to Buy: What Does It Mean for the Stock? Rapid Micro Biosystems (RPID) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). | ||
 Rapid Micro Biosystems, Inc. Q2 2026 Earnings Call Summary Moby summary of Rapid Micro Biosystems, Inc.'s Q2 2026 earnings call | ||
Rapid Micro Biosystems Inc (RPID) (Q2 2026) Earnings Call Highlights: Record Revenue and ... Company exceeds Q2 guidance with 11% revenue growth and record gross margin, while reaffirming full-year outlook and advancing key partnerships. | ||
 Rapid Micro Biosystems Q2 Earnings Call Highlights Rapid Micro Biosystems (NASDAQ:RPID) reported second-quarter revenue of $8.1 million, up 11% from $7.3 million a year earlier and above the company’s prior guidance, as consumable sales, service activity and recurring revenue increased. The company placed four Growth Direct Systems during the quart | ||
 Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Tops Revenue Estimates Rapid Micro Biosystems (RPID) delivered earnings and revenue surprises of -3.85% and +3.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock? | ||
 Hyperfine, Inc. (HYPR) Reports Q2 Loss, Lags Revenue Estimates Hyperfine (HYPR) delivered earnings and revenue surprises of 0.00% and -7.71%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock? | ||
 Sight Sciences, Inc. (SGHT) Reports Q2 Loss, Tops Revenue Estimates Sight Sciences (SGHT) delivered earnings and revenue surprises of +46.67% and +7.55%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock? | ||
Rapid Micro Biosystems, Inc. Q1 2026 Earnings Call Summary Moby summary of Rapid Micro Biosystems, Inc.'s Q1 2026 earnings call | ||